Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Ohio Center for Treatment and Research in Multiple Sclerosis is a specialized clinical and research institution based in Columbus, Ohio, dedicated to the management and study of multiple sclerosis. Operating closely with the Multiple Sclerosis Center of Central Ohio, the facility provides comprehensive neurological care, including diagnostic services, infusion therapy, and multidisciplinary rehabilitation. It is a highly active clinical trial site, participating in numerous Phase 2 and Phase 3 studies for major pharmaceutical sponsors to evaluate next-generation MS therapies. The center is recognized for its contribution to the clinical development of widely used MS treatments, such as Ocrevus and Gilenya, and its commitment to patient-centered research. Its mission focuses on improving patient outcomes through both advanced clinical practice and rigorous scientific investigation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ohio Center for Treatment and Research in Multiple Sclerosis.